Study directory

Anxiety studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4175studies shown
Showing 1,789-1,800 of 4,175
Drug study icon
CompletedEUCTR 2005-003181-41

An eight-week, double-blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy, safety and tolerability of a fixed dose of SR58611A (350...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugA study involving a medication or substance.
Countries
Austria, Estonia, Sweden
Sponsor
Sanofi-Synthelabo Recherche
Condition
Anxiety
Drug study icon
CompletedEUCTR 2009-010902-13

Duloxetina versus placebo en el tratamiento de pacientes de avanzada edad con trastorno de ansiedad generalizada Duloxetine versus Placebo in the Treatment of Elderly Patients with Generalized Anx...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrug
Countries
United Kingdom, Austria, Germany, ...
Sponsor
LILLY S.A.
Condition
Anxiety
Behavioral study icon
CompletedNCT04560595

Remote Guided Caffeine Reduction

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Anxiety.

AnxietyBehavioralFrom 18 Years to 75 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Anxiety
Behavioral study icon
Not recruitingISRCTN95058526

Is hydrogen water intervention and cognitive-behavioral group therapy effective in women suffering from panic attacks?

This study is looking at whether a digital support tool can help people with anxiety and associated inflammatory response in women with anxiety attacks from the perspective of the gut-brain-microbiota axis or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

In Spain
Why is this study shown?

This study is directly about Anxiety.

AnxietyOtherOver 18 Years
Countries
Spain
Sponsor
Universidad Católica San Antonio de Murcia
Condition
Anxiety
Behavioral study icon
Not recruitingISRCTN86795807

Nurture-U: reducing worry and building confidence in university students

This study is looking at whether cognitive behavioural therapy can help people with Students with elevated worry and anxiety or Mental and Behavioural Disorders. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Anxiety.

AnxietyOtherOver 16 Years
Countries
United Kingdom
Sponsor
University of Exeter
Condition
Anxiety
Drug study icon
CompletedEUCTR 2006-001475-38

A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Anxiety.

Anxiety, DepressionDrug
Countries
Netherlands
Sponsor
Janssen Cliag Ltd. C/O Johnson & Johnson PRD
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2005-003006-29

A Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of the Anxiolytic Efficacy of Pregabalin and Alprazolam IR in Subjects with Anxiety prior to Dental Procedure

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrug
Countries
United Kingdom, Germany
Sponsor
Pfizer Limited
Condition
Anxiety
Drug study icon
CompletedEUCTR 2017-002263-17

Efficacy and safety of Passiflora Compose in patients newly diagnosed with adjustment disorder with anxiety, as first-line treatment, compared to alprazolam

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrug
Countries
France
Sponsor
BOIRON
Condition
Anxiety
Drug study icon
TerminatedEUCTR 2006-005506-32

Pain, anxiety and depression in neuropathic and non-neuropathic pain: Effect of monoamine modulation.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Anxiety.

Anxiety, DepressionDrug
Countries
Denmark
Sponsor
Danish Pain Research Center
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2007-004009-93

Prevalence of depression,anxiety and impulse control disorder (ICD) in patients with Parkinson's disease and effectiveness of escitalopram

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Anxiety.

Anxiety, DepressionDrug
Countries
Italy
Sponsor
LUNDBECK ITALIA
Condition
Anxiety, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.